Clinical Trials
3 trialsNCT00084656 2022-04-14
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
Bristol-Myers Squibb
Phase 2 Completed
NCT00153569 2010-05-26
Multiepitope Peptide Vaccination in Melanoma
Charite University, Berlin, Germany
Phase 2 Unknown
NCT00001685 2008-03-04
Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase
National Institutes of Health Clinical Center (CC)
Phase 2 Completed